Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
09/2003
09/24/2003EP1347042A1 A virus which can express tumor angiostatin factor with high efficiency in specific tumor cells and the use of it
09/24/2003EP1346725A1 Pharmaceutical composition comprising PIM-activated NKT cells, and therapeutic use thereof
09/24/2003EP1346217A2 Reversible mhc multimer staining for functional purification of antigen-specific t cells
09/24/2003EP1346061A2 Pregnancy-associated plasma protein-a2 (papp-a2)
09/24/2003EP1346059A1 Photochemical internalization for delivery of molecules into the cytosol
09/24/2003EP1346058A2 Adenoviral systems and the uses thereof
09/24/2003EP1345961A2 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same
09/24/2003EP1345743A1 Electroprocessed collagen
09/24/2003EP1345624A1 Induction of tolerance
09/24/2003EP1345613A2 Probiotic compounds derived from lactobacillus casei strain ke01
09/24/2003EP1345574A2 Improvement of graft acceptance through manipulation of thymic regeneration
09/24/2003EP1345501A1 Nutritional and therapeutical preparations having antioxidant activity
09/24/2003EP1345491A1 Storage solution containing photosensitizer for inactivation of biological contaminants
09/24/2003EP1227826B1 Composition comprising an extract of perna canaliculus, methylsulfonylmethane and glucosamine and use thereof
09/24/2003EP1098656B1 Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof
09/24/2003EP1095132A4 Methods for implanting cells
09/24/2003EP1094829B1 Methods for accelerating bone and cartilage growth and repair
09/24/2003EP0922093B1 Method for making cartilage and implants
09/24/2003EP0918509B1 Biocompatible devices with foam scaffolds
09/24/2003EP0845963B1 The use of autologous dermal fibroblasts for the repair of skin and soft tissue defects
09/24/2003EP0741550B1 Multiple layer alginate coatings of biological tissue for transplantation
09/24/2003CN1444648A Method of amplifying natural killer T cells
09/24/2003CN1444647A Novel probiotics for pet. food applications
09/24/2003CN1444486A Use of interferon receptor 2c polypeptide chain to enhance anti-growth effects of type I interferons
09/24/2003CN1444484A Immunotherapy treating bacterial or viral infection at mucosal surface with probiotics, and composition therefor
09/24/2003CN1444474A Nonoral preparation having three-layer structure
09/24/2003CN1444469A Use of exogenous lactic bacteria strain against actinomyces naeslundii related diseases
09/24/2003CN1443576A Production method of chondric implant
09/24/2003CN1443542A Nocardioactinomycetes cell wall skeleton preparation
09/24/2003CN1443541A Ass hide glue ferrous oral liquor and its production method
09/24/2003CN1121874C Immunotherapeutic agent and its use
09/24/2003CN1121872C Gastrodia elata tea for curing hypertension
09/24/2003CN1121868C Traditional Chinese medicine prepn. for curing rheumation and its preparing process
09/24/2003CN1121867C Medicine for preventing and treating abortion and its preparing process
09/24/2003CN1121866C Chinese medicine for treating man's sexual disfunction and its preparing process
09/24/2003CN1121864C Bifidoquater live bacterial chip
09/24/2003CN1121863C Process for preparing medicinal attapulgite
09/23/2003US6624151 Concerns the uses of said compounds as selective inhibitors of T gamma 9 delta 2 lymphocytes, their uses, for therapeutic purposes.
09/23/2003US6623952 Infectious; of given sequence; may be used as a vector for gene therapy, in a vaccine or for detection of viruses for xenotransplantation
09/23/2003US6623951 HBV vectors and cells for producing the same
09/23/2003US6623767 Mixture containing honey, at least one essential oil and/or at least one essential oil derivative
09/23/2003US6623733 Harvesting tissue cells; lysing and filtering; administering angiogenic filtrate
09/23/2003CA2281570C Composition for treating tumors containing shark cartilage extracts and anti-neoplastic agents
09/23/2003CA2129630C Method of increasing the concentration of nitric oxide in blood
09/20/2003CA2377442A1 Increasing tumor oxygen content by administration of stressed cells
09/18/2003WO2003076950A2 Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders
09/18/2003WO2003076605A1 A method for producing recombinant viruses using site-specific recombination
09/18/2003WO2003076603A2 Functionalization of t cell derived vesicles and use thereof for the preparation of immunogenic pharmaceutical compositions
09/18/2003WO2003076594A2 Genomic screen for epigenetically silenced tumor suppressor genes
09/18/2003WO2003076591A2 Compositions and methods for generating an immune response
09/18/2003WO2003076570A2 Antigens and their use as diagnostics and vaccines against species of plasmodium
09/18/2003WO2003076564A2 Tissue-engineered organs
09/18/2003WO2003075942A1 Vitamin and zinc monomethionine compositions
09/18/2003WO2003075936A1 Rearing of snakes for producing poison components
09/18/2003WO2003075868A1 Sourdough-based skin medication and skin care product, and production method
09/18/2003WO2003075843A2 Multiple and multivalent dna vaccines in ovo
09/18/2003WO2003075827A2 Use of mycobacterium w in the treatment of asthama(obstructive lung disease)
09/18/2003WO2003075826A2 Process for manufacturing pharmaceutical composition comprises of mycobacterium w in the treatment of asthma(obstructive lung disease)
09/18/2003WO2003075825A2 The method of treating tuberculosis
09/18/2003WO2003075676A1 Probiotic delivery system
09/18/2003WO2003043517A3 Dentifrice compositions
09/18/2003WO2003033692A3 Use of the adenoviral e2 late promoter
09/18/2003WO2003026584A3 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
09/18/2003WO2003025191A3 Pseudotyped retroviral vector system
09/18/2003WO2003024472A3 Prolactin induced increase in neutral stem cell numbers and therapeutical use thereof
09/18/2003WO2003018782A3 Differentiation of neural stem cells and therapeutic use theeof
09/18/2003WO2003012060A9 Cellular compositions which facilitate engraftment of hematopoietic stem cells while minimizing the risk of gvhd
09/18/2003WO2002080982A3 Nucleic acid mucosal immunization
09/18/2003WO2002072027A3 Oncolytic rna replicons
09/18/2003WO2002066646A3 Neurotransmission-associated proteins
09/18/2003WO2002053177A3 Agents and methods for treating pain
09/18/2003US20030176393 Product of heat treatment of uronic acid, food, drink or drug including the product
09/18/2003US20030176381 Hyaluronic acid in the treatment of cancer
09/18/2003US20030176377 DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof
09/18/2003US20030176372 Anti-virus agent
09/18/2003US20030176349 Stable hypoxia inducible factor-1 alpha and method of use
09/18/2003US20030176331 Having therapeutic, diagnostic, and preventative benefits, particularly as immunotoxins; for therapy of cancer
09/18/2003US20030175963 Platform for the differentiation of cells
09/18/2003US20030175955 Immortalization stem cell; animal growth regulators; formingantibodies
09/18/2003US20030175954 Human embryoid body-derived cells
09/18/2003US20030175917 Method of sorting cells
09/18/2003US20030175711 Comprises ordered and repetitive antigen or antigenic determinant array for developing vaccines for treatment of infectious diseases, allergies and cancer; microarrays
09/18/2003US20030175688 Preparing replication competent viral vectors for treating cancer; genetic vaccines; gene therapy; antitumor agents
09/18/2003US20030175371 Antimicrobial agents isolated from Aloe vera
09/18/2003US20030175363 Pharmaceutical composition and process for isolation of trans-tetracos-15-enoic acid and method of treatment for hepatotoxicity
09/18/2003US20030175359 Egg treated to add 4.2 ppm or more iodine
09/18/2003US20030175307 Treating intestinal infections in a ruminant by administering a Lactobacillus acidophilus strain, able producing lactic acid; gastrointestinal disorders, veterinary medicine; increasing the fat content of milk produced by a dairy cow
09/18/2003US20030175306 Treating intestinal infections in a ruminant by administering a Lactobacillus acidophilus strain, able producing lactic acid; gastrointestinal disorders, veterinary medicine; increasing the fat content of milk produced by a dairy cow
09/18/2003US20030175305 Compositions and methods for inhibiting pathogenic growth
09/18/2003US20030175292 Compositions and methods for generating an immune response
09/18/2003US20030175291 Multiple and multivalent DNA vaccines in ovo
09/18/2003US20030175290 Molecular antigen array
09/18/2003US20030175277 Administering mixtures of antigens and phospholipase inhibitors as antitumor or anticarcinogenic agents
09/18/2003US20030175261 Captopril; hyaluronidases; phospholipases
09/18/2003US20030175257 Cartilage regeneration using chondrocyte and TGF-beta
09/18/2003US20030175256 Allografts comprising undifferentiated fetal skin cells integrated within collagen matrix
09/18/2003US20030175250 Isolated peptides which bind to HLA molecules and uses thereof
09/18/2003US20030175248 Comprises thrombocyte-rich plasm and calcium phosphates for use in skin and bone defects
09/18/2003US20030175247 For activating lymphocytes (CD-8 antigens) in response to metastatic cancer; tumor associated antigens; major histocompatibility complex; cryopreservation; prostate specific antigen
09/18/2003US20030175246 Toxin-phage bacteriocide antibiotic and uses thereof
1 ... 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 ... 1259